1093190-16-9

Basic information

• Product Name: [2-(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)ethynyl]trimethylsilane
• Synonyms: [2-(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)ethynyl]trimethylsilane
• CAS NO: 1093190-16-9
• Molecular Weight: 318.607
• Mol File: 1093190-16-9.mol

Chemical Properties

• CAS DataBase Reference: [2-(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)ethynyl]trimethylsilane(CAS DataBase Reference)
• NIST Chemistry Reference: [2-(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)ethynyl]trimethylsilane(1093190-16-9)
• EPA Substance Registry System: [2-(4-{[(tert-butyldimethylsilyl)oxy]methyl}phenyl)ethynyl]trimethylsilane(1093190-16-9)

Safety Data

• Hazardous Substances Data: 1093190-16-9(Hazardous Substances Data)

Upstream product

• 15164-44-0 p-(iodophenyl)carboxaldehyde 
• 18282-51-4 4-iodo-benzyl alcohol 
• 87736-74-1 4-(tert-butyldimethylsiloxymethyl)bromobenzene 
• 1066-54-2 trimethylsilylacetylene 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 873-75-6 4-bromobenzenemethanol 
• 75867-41-3 4-trimethylsilanylethynyl-benzoic acid methyl ester 
• 619-42-1 4-methoxycarbonylphenyl bromide 
• 275386-60-2 4-(hydroxymethyl)-1-(trimethylsilylethynyl)benzene 
• 147283-96-3 4-(tert-butyldimethylsiloxymethyl)iodobenzene 

Downstream Products

• 1093190-17-0 tert-butyl[(4-ethynylphenyl)methoxy]dimethylsilane 
• 1360803-52-6 3-(4-(prop-1-yn-1-yl)phenyl)propionic acid ethyl ester 
• 1360803-56-0 methyl 2-(N-(4-(prop-1-yn-1-yl)benzyl)-3-(4-(prop-1-yn-1-yl)phenyl)propanamido)acetate-d₅ 
• 1360803-57-1 2-(N-(4-(prop-1-yn-1-yl)benzyl)-3-(4-(prop-1-yn-1-yl)phenyl)propanamido)acetic acid-d5 
• 82657-70-3 4-n-propylbenzyl alcohol 
• 1360803-33-3 1-(iodomethyl)-4-propylbenzene 
• 1360803-34-4 methyl 2-((4-propylbenzyl)amino)acetate 
• 1360803-48-0 1-(iodomethyl)-4-(prop-1-yn-1-yl)benzene 
• 1360803-46-8 (4-(prop-1-yn-1-yl) phenyl)methanol 
• 1360803-50-4 diethyl 2-(4-(prop-1-yn-1-yl)benzyl)malonate 
• 1360803-54-8 3-(4-(prop-1-yn-1-yl)phenyl)propionic acid 
• 1360803-55-9 methyl 2-((4-(prop-1-yn-1-yl)benzyl)amino)acetate 
• 1360803-61-7 C₂₈H₂₁⁽²⁾H₅N₂O₅ 
• 1224716-84-0 4-propylbenzyl methanesulfonate 

Relevant articles and documents

Regioselective Termination Reagents for Ring-Opening Alkyne Metathesis Polymerization

Alkyne cross-metathesis of molybdenum carbyne complex [TolC≡Mo(OCCH3(CF3)2)3]·DME with 2 equiv of functional ynamines or ynamides yields the primary cross-metathesis product with high regioselectivity (>98%) along with a molybdenum metallacyclobutadiene complex. NMR and X-ray crystal structure analysis reveals that ynamides derived from 1-(phenylethynyl)pyrrolidin-2-one selectively cleave the propagating molybdenum species in the ring-opening alkyne metathesis polymerization (ROAMP) of ring-strained 3,8-dihexyloxy-5,6-dihydro-11,12-didehydrodibenzo[a,e][8]annulene and irreversibly deactivate the diamagnetic molybdenum metallacyclobutadiene complex through a multidentate chelate binding mode. The chain termination of living ROAMP with substituted ethynylpyrrolidin-2-ones selectively transfers a functional end-group to the polymer chain, giving access to telechelic polymers. This regioselective carbyne transfer strategy gives access to amphiphilic block copolymers through synthetic cascades of ROAMP followed by ring-opening polymerization of strained ?-caprolactone.

NOVEL TARGETING AGENTS FOR DIAGNOSTIC AND THERAPEUTIC INDICATIONS

The invention relates to compounds and use thereof in the diagnosis and/or in treatment of medical disorders. In some embodiments, the compounds may be used for detecting a cancer. The compound may include a di-acid moiety. In some embodiments the di-acid moiety comprises a di-carboxylic acid and in some embodiments the di- acid moiety comprises a di-tetrazole.

LABELING AGENT AND AMINO ACID SEQUENCE USING SAME, AND METHOD FOR PERFORMING SIMULTANEOUS QUANTITATIVE ANALYSIS OF MULTIPLE PROTEINS

The present invent ion provides a compound that can utilize hydrogen isotope and, at the same time, can quantify multiplexed samples at one time, as well as decreasing the cost for synthesis of the labeling agent. In addition, the present invention provid

ANTIBACTERIAL AGENTS

Antibacterial compounds of formula (I) are provided, as well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of such compounds.